News

Fierce Pharma1d
Merck's Keytruda wins breakthrough head and neck cancer nod around surgery, but with a limitation
Merck & Co.’s Keytruda has become the first immunotherapy approved by the FDA to be used around surgery to treat resectable ...
Targeted Oncology5h
KEYNOTE-689 Leads to FDA Approval of Perioperative Pembrolizumab in HNSCC
Ravindra Uppaluri, MD, PhD, discusses the background regarding locally advanced head and neck cancer and what the trial design of KEYNOTE-689 entailed.
CURE22h
FDA Approves Perioperative Keytruda for Locally Advanced Head and Neck Cancer
Keytruda was approved for locally advanced head and neck cancer before and after surgery, showing improved event-free ...
Merck's Keytruda Secures FDA Nod For Head And Neck Cancer As First Immunotherapy For Use Around Surgery
Merck's Keytruda receives FDA approval for head and neck cancer after showing improved event-free survival in Phase 3 KEYNOTE ...
From feeling scared about her IV in her neck to receiving a shy welcome from son Ruhaan; Dipika Kakar is back home from hospital post her surgery
Dipika Kakar, who got diagnosed with 2nd stage liver cancer, is finally back home after her major liver tumour surgery. In ...